About this trial
The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.
Eligibility criteria
Qualifiers
Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis.
A sum score above 19 on the primary outcome measure (Kessler-10).
An age of 18 or older.
Ability to speak, read, and write Swedish.
Disqualifiers
Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period.
Recently finished (within the past six months) medical treatment for prostate cancer.
Severe psychiatric or somatic conditions that impedes participation in the study.
Ongoing substance use problems.
Trial design
Treatments tested in this trial
- Internet-based cognitive behavioral therapy
- Non-directive support
Treatment groups
Sponsors and collaborators
Linkoeping University
Lead sponsor
University Hospital, Linkoeping
Collaborator